Astrana Health, Inc.
ASTH
$24.19
-$0.08-0.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 85.41% | 453.95% | 60.66% | -43.35% | -13.15% |
| Total Other Revenue | 42.53% | 97.67% | 34.57% | 54.41% | 90.30% |
| Total Revenue | 42.89% | 99.71% | 34.66% | 53.43% | 88.43% |
| Cost of Revenue | 39.16% | 111.95% | 39.74% | 66.18% | 95.74% |
| Gross Profit | 88.28% | 32.25% | 6.14% | -3.55% | 29.50% |
| SG&A Expenses | 46.63% | 37.79% | 41.09% | 9.73% | 9.71% |
| Depreciation & Amortization | 101.83% | 114.69% | -7.22% | 34.40% | 65.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.40% | 105.77% | 39.08% | 59.91% | 86.18% |
| Operating Income | 2,343.75% | 3.82% | -32.35% | -27.04% | 118.60% |
| Income Before Tax | 496.09% | -78.85% | -47.25% | -59.99% | -305.09% |
| Income Tax Expenses | -83.95% | -41.34% | -34.11% | -52.63% | 477.80% |
| Earnings from Continuing Operations | 184.38% | -94.33% | -53.28% | -63.11% | -8,173.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -168.16% | 75.61% | 70.58% | 123.24% | -93.37% |
| Net Income | 186.30% | -97.68% | -50.85% | -54.89% | -156.26% |
| EBIT | 2,343.75% | 3.82% | -32.35% | -27.04% | 118.60% |
| EBITDA | 284.31% | 26.39% | -27.37% | -18.15% | 757.17% |
| EPS Basic | 181.27% | -97.75% | -52.41% | -56.01% | -157.69% |
| Normalized Basic EPS | 251.67% | -33.33% | -45.70% | -41.42% | -104.99% |
| EPS Diluted | 181.27% | -97.70% | -52.50% | -55.45% | -158.09% |
| Normalized Diluted EPS | 250.83% | -32.96% | -45.58% | -41.34% | -104.99% |
| Average Basic Shares Outstanding | 6.24% | 3.21% | 3.30% | 2.56% | -2.49% |
| Average Diluted Shares Outstanding | 6.88% | 2.59% | 3.11% | 2.41% | -2.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |